PRELUDE THERAPEUTICS INC (PRLD) Stock Cash Flow
NASDAQ:PRLD - Nasdaq - US74065P1012 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -127.17M | -121.83M | -115.44M | -111.69M | -56.93M | |||
| Depreciation Amortization | 1.77M | 1.17M | 1.32M | 920.00K | 540.00K | |||
| Change In Working Capital | 4.22M | -10.48M | 930.00K | 3.63M | 4.62M | |||
| Other non cash items | 18.30M | 24.08M | 29.45M | 23.62M | 5.59M | |||
| OPERATING CASH FLOW | -102.89M | -107.06M | -83.73M | -83.53M | -46.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -764.00K | -3.51M | -3.02M | -2.32M | -620.00K | |||
| Other Investing Activity | 90.95M | -31.13M | 84.71M | -261.48M | N/A | |||
| INVESTING CASH FLOW | 90.19M | -34.65M | 81.69M | -263.80M | -620.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -395.00K | N/A | N/A | N/A | -260.00K | |||
| Stock Issued/Repurchased | 439.00K | 136.41M | 820.00K | 165.20M | 246.50M | |||
| Other Financing Activity | -164.00K | -17.00K | 0.00 | -300.00K | -10.00K | |||
| FINANCING CASH FLOW | -120.00K | 136.40M | 820.00K | 164.90M | 246.23M | |||
| CHANGE IN CASH | -12.82M | -5.31M | -1.22M | -182.43M | 199.43M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -102.89M | -107.06M | -83.73M | -83.53M | -46.18M | |||
| Capital Expenditure | -764.00K | -3.51M | -3.02M | -2.32M | -620.00K | |||
| FREE CASH FLOW | -103.65M | -110.58M | -86.75M | -85.85M | -46.80M | |||
All data in USD